
Chinese prepared Chinese medicine company founded in September 2007 in Sichuan and quoted on China's NEEQ market under code 836450, running an integrated chain from breeding and standardised cultivation of authentic Sichuan medicinal materials through processing technique preservation and innovation, quality standard improvement, clinical validation and promotion. Specialises in fermented decoction pieces led by Liushenqu and Dannanxing, single-herb pieces led by Hemsleya and Rhodiola, and consumer health products such as Hemsleya toothpaste. A national high-tech enterprise and Sichuan specialised and innovative SME, it hosts a Sichuan engineering technology research centre for fermented Chinese medicines and a provincial enterprise technology centre, and its traditional Liushenqu processing technique is listed as Sichuan intangible cultural heritage. Recorded 86.18 million yuan of revenue in 2022 with 45 staff, 62 trademarks and 29 patents.
Laissez votre note